Home/Filings/4/0001415889-23-009193
4//SEC Filing

Jensen Claus Torp 4

Accession 0001415889-23-009193

CIK 0001477449other

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 4:06 PM ET

Size

12.7 KB

Accession

0001415889-23-009193

Insider Transaction Report

Form 4
Period: 2023-06-01
Jensen Claus Torp
Chief Innovation Officer
Transactions
  • Sale

    Common Stock

    2023-06-02$24.38/sh4,635$113,00626,190 total
  • Exercise/Conversion

    Common Stock

    2023-06-01+2,80722,650 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-06-012,80719,652 total
    Common Stock (2,807 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2023-06-018,17516,350 total
    Common Stock (8,175 underlying)
  • Exercise/Conversion

    Common Stock

    2023-06-01+8,17530,825 total
Footnotes (4)
  • [F1]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F2]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
  • [F3]On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F4]On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Issuer

Teladoc Health, Inc.

CIK 0001477449

Entity typeother

Related Parties

1
  • filerCIK 0001857993

Filing Metadata

Form type
4
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:06 PM ET
Size
12.7 KB